Description
TARLATAMAB (IMDELLTRA) 1MG AND 10MG SDV KITS
First action · last action
2024-06-26 · 2024-07-23
Transactions
2
First transaction's obligation
$91,500
Base + all options value (sum of deltas)
$16,500
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-06-26+$91,500= $91,500
- Mod P000012024-07-23-$75,000= $16,500
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-06-26 | +$91,500 | $91,500 | TARLATAMAB (IMDELLTRA) 1MG AND 10MG SDV KITS |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2024-07-23 | −$75,000 | $16,500 | TARLATAMAB (IMDELLTRA) 1MG AND 10MG SDV KITS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI VMJLFQE5U511)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24225P1011 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $4,853 | FY2025 |
| 36C24825P0474 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $11,859 | FY2025 |
| 36E79724D0028 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C25024P0630 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $20,786 | FY2024 |
| 36C25024P0413 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $5,196 | FY2024 |
| 36C24224P0289 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $10,312 | FY2024 |
Other recipients under 6505 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25026P0991 | ASD SPECIALTY HEALTHCARE, LLC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $43,680 | FY2026 |
| 36C25026F0668 | COSETTE PHARMACEUTICALS, INC. | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $10,398 | FY2026 |
| 36C25026N0655 | PROGENICS PHARMACEUTICALS INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $721,744 | FY2026 |
| 36C25026N0616 | AMERICAN NATIONAL RED CROSS, THE | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $37,180 | FY2026 |
| 36C25026D0061 | AMERICAN NATIONAL RED CROSS, THE | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25024P1401_3600_-NONE-_-NONE- · retrieved 2026-09-26.